DrugPatentWatch Database Preview

Bausch And Lomb Company Profile

« Back to Dashboard

What is the competitive landscape for BAUSCH AND LOMB, and what generic alternatives to BAUSCH AND LOMB drugs are available?

BAUSCH AND LOMB has seventy-seven approved drugs.

There are twenty-eight US patents protecting BAUSCH AND LOMB drugs.

There are two hundred and twenty-nine patent family members on BAUSCH AND LOMB drugs in forty-two countries and fifty-one supplementary protection certificates in eleven countries.

Summary for Bausch And Lomb

International Patents:	229
US Patents:	28
Tradenames:	66
Ingredients:	54
NDAs:	77
Patent Litigation for Bausch And Lomb:	See patent lawsuits for Bausch And Lomb

Drugs and US Patents for Bausch And Lomb

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch And Lomb	HYDROCORTISONE AND ACETIC ACID	acetic acid, glacial; hydrocortisone	SOLUTION/DROPS;OTIC	040097-001	Oct 31, 1994		DISCN	No	No
Bausch And Lomb	TOBRAMYCIN	tobramycin	SOLUTION/DROPS;OPHTHALMIC	064052-001	Nov 29, 1993	AT	RX	No	No
Bausch And Lomb Inc	XIBROM	bromfenac sodium	SOLUTION/DROPS;OPHTHALMIC	021664-001	Mar 24, 2005		DISCN	Yes	No
Bausch And Lomb	ALAWAY	ketotifen fumarate	SOLUTION/DROPS;OPHTHALMIC	021996-002	Feb 11, 2015		OTC	Yes	No
Bausch And Lomb	BESIVANCE	besifloxacin hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	022308-001	May 28, 2009		RX	Yes	Yes	8,604,020		Y
Bausch And Lomb	PROLENSA	bromfenac sodium	SOLUTION/DROPS;OPHTHALMIC	203168-001	Apr 5, 2013		RX	Yes	Yes	9,561,277

Expired US Patents for Bausch And Lomb

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch And Lomb Inc	LOTEMAX	loteprednol etabonate	GEL;OPHTHALMIC	202872-001	Sep 28, 2012	5,800,807
Bausch And Lomb	ALREX	loteprednol etabonate	SUSPENSION/DROPS;OPHTHALMIC	020803-001	Mar 9, 1998	5,540,930*PED
Bausch And Lomb	ALREX	loteprednol etabonate	SUSPENSION/DROPS;OPHTHALMIC	020803-001	Mar 9, 1998	4,996,335*PED
Bausch And Lomb	VITRASERT	ganciclovir	IMPLANT;IMPLANTATION	020569-001	Mar 4, 1996	5,378,475
Bausch And Lomb	ALREX	loteprednol etabonate	SUSPENSION/DROPS;OPHTHALMIC	020803-001	Mar 9, 1998	5,747,061*PED
Bausch And Lomb Inc	XIBROM	bromfenac sodium	SOLUTION/DROPS;OPHTHALMIC	021664-001	Mar 24, 2005	4,910,225

Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Ophthalmic Solution	0.5%		2012-10-19
	Ophthalmic Solution	1.5%		2013-09-09
	Ophthalmic Solution	0.07%		2013-07-26

International Patents for Bausch And Lomb Drugs

Country	Document Number	Estimated Expiration
South Korea	20050092691
Spain	2566800
Portugal	2320911
World Intellectual Property Organization (WIPO)	9922715
Hong Kong	1041642
Malaysia	118016

Supplementary Protection Certificates for Bausch And Lomb Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2015 00017	Denmark		PRODUCT NAME: TOBRAMYCIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/10/652/001-003 20110720
2015000061	Germany		PRODUCT NAME: TRASTUZUMAB UND RECOMBINANTE HUMANE HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
C0041	Belgium		PRODUCT NAME: LEVOFLOXACINUM HEMIHYDRICUM; NAT. REGISTRATION NO/DATE: 354 IS 370 F3 19980624; FIRST REGISTRATION: GB 134020011 19970606
00683	Netherlands		PRODUCT NAME: BRIMONIDINE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN VOOR TOEPASSING ALS GENEESMIDDEL VOOR DE BEHANDELING VAN DOOR ROSACEA GEINDUCEERDE ROODHEID; REGISTRATION NO/DATE: EU/1/13/904 20140225
C0111	Belgium		PRODUCT NAME: LATANOPROSTUM; NAT. REGISTRATION NO/DATE: 277 IS 271 F 13 19970617; FIRST REGISTRATION: SE 12716 1996071
00722	Netherlands		PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Bausch And Lomb
• Bausch And Lomb Inc